CL

Some dividend stocks raise their payouts through one recession, maybe two.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Colgate-Palmolive remains a Buy, offering defensive qualities, a resilient global portfolio, and an attractive margin of safety at current valuation. Q2 results showed 4.9% net sales growth and 8% base EPS growth, with strong performance outside North America and continued innovation driving market share gains. CL maintains robust free cash flow, supports a 2.36% dividend yield, and continues share repurchases, underpinned by manageable debt and disciplined capital allocation.

Boring works. Over a market cycle, essential-service businesses tend to keep selling toothpaste, chips, and industrial adhesives regardless of what the S&P 500 is doing on any given afternoon.

Two of the market's most reliable dividend payers just cut checks to shareholders within days of each other. Procter & Gamble (NYSE:PG | PG Price Prediction) paid $1.0885 per share on August 17, 2026, while Colgate-Palmolive (NYSE:CL) paid $0.

CL raised its 2026 profit outlook after a Q2 earnings beat and 140-basis-point margin gain, while higher costs and North America remain risks.

CL enters the second half with better volumes, resilient margins and a higher earnings outlook, but rich valuation and U.S. weakness temper the upside.

CL slips below its 50-day SMA as U.S. softness, competition and rising costs weigh despite solid Q2 growth and global momentum.

Colgate's Q2 revenues rise 4.9% as emerging markets, Europe and Hill's drive growth, but U.S. weakness and rising costs cloud the second-half outlook.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.